United States · FDA National Drug Code directory
TRYNGOLZA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71860-102_55b4730e-4610-c0f2-e063-6294a90a90ae
- Product NDC
- 71860-102
- Form
- INJECTION, SOLUTION
- Composition / generic term
- olezarsen sodium
- Labeler
- Ionis Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260624
- Source listing expiry
- 20271231
Source-listed ingredients
- OLEZARSEN SODIUM — 50 mg/.8mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (71860-102-01) / .8 mL in 1 SYRINGE, GLASS · 71860-102-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →